Karen J. Ferrante
Overview
Karen J. Ferrante received an average of $1M in total compensation, including $315K in salary, at Tokai Pharmaceuticals between 2014 and 2015.
Source: SEC filing on April 29, 2016.
Related executives
We found 11 more executives who work or worked at Tokai Pharmaceuticals.
Paul Little
Tokai Pharmaceuticals
Chief Financial Officer
Bryan Smith
Tokai Pharmaceuticals
General Counsel
David-Alexandre Gros
Tokai Pharmaceuticals
Chief Executive Officer
Gregory Flesher
Tokai Pharmaceuticals
Chief Executive Officer
Catherine Turkel
Tokai Pharmaceuticals
President
Jon Kuwahara
Tokai Pharmaceuticals
Senior Vice President of Finance and Administration
Jodie Morrison
Tokai Pharmaceuticals
Chief Executive Officer
John McBride
Tokai Pharmaceuticals